The purpose of this report, prepared by the Pan American Health Organization, is to document progress in vaccination coverage against COVID-19.
The data presented below are provided by the country or are extracted from their reports published on their official sites (see References). The data analyzed comes from the consolidation of vaccines administered since the country began vaccination against COVID-19, incorporating variables that allow deepening the coverage analysis.
The differences between countries regarding the vaccines used and the defined schedules lead to presenting the data considering single doses and first doses (consolidated under the category “At Least One Dose”), as well as the final dose of the primary schedule (in schedules with more than one dose). Those countries that have started booster/additional doses are also reflected in this report.
Demographic data is shown below, based on the United Nations (UN) Population Prospects for 2021 and projections from the United States (US) Census Bureau for countries with 100,000 or fewer inhabitants. It is important to note that these population denominators are used throughout the document for the calculation of coverage percentages.
A descriptive and graphical breakdown of the different vaccine manufacturers used.
From the start of vaccination to the date of this report, a total of 41,198 doses of vaccines against COVID-19 have been administered.
Monthly uptake reflects the coverage and additional dose increase on a per-month basis.
The number of accumulated administered doses up to week 26 of the year 2022 are shown below, differentiating according to the schedules offered (e.g. completed primary series and additional/booster doses). Note that not all countries have information on ‘Single Dose’ since they have not purchased single-dose vaccines, or it is not possible to disaggregate the information. Similarly, not all countries may have introduced additional/booster doses for their population.
The following graph shows the progress of vaccination coverage against COVID-19. Data are analyzed at the national level, considering at least one dose and complete primary series with booster/additional doses. In addition, the dropout rate was incorporated, which allows evaluating adherence to the immunization process, that is, what percentage of those who received a first dose against COVID-19 completed the primary vaccination schedule established in the country.
The following table shows the total doses administered at the national level, differentiated by risk group. Only the information available is presented, although it is possible that not all the target groups defined by the country are reflected.
The following graph shows the progress of vaccination at the national level differentiated by sex, the analysis considers only the complete primary schedule.
The healthcare worker analysis aims to show the raw amount of vaccinated healthcare workers. It considers at least one dose, fully vaccinated individuals (i.e. those who have completed the primary schedule) and additonal doses/boosters.